Non-stimulant treatment for Attention-Deficit/Hyperactivity Disorder

Journal of Attention Disorders

Volumn 6, Issue SUPPL. 1, 2002, Pages

  Spencer, Thomas ^a,b   Biederman, Joseph ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; 3-METHYL-5-(1-METHYL-2-PYRROLIDINYL)ISOXAZOLE; CENTRAL NERVOUS SYSTEM AGENTS; CHOLINESTERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; ISOXAZOLE DERIVATIVE; NOOTROPIC AGENT; NORADRENALIN; PYRROLIDINE DERIVATIVE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG POTENTIATION; HUMAN; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM AGENTS; CHILD; CHOLINESTERASE INHIBITORS; CLINICAL TRIALS; DOPAMINE AGENTS; HUMANS; ISOXAZOLES; NOOTROPIC AGENTS; NOREPINEPHRINE; PYRROLIDINES; TREATMENT OUTCOME;

EID: 0141732801     PISSN: 10870547     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370200601s13     Document Type: Review

References (104)

1. Abramowicz, M. (1990). Sudden death in children treated with a tricyclic antidepressant. The Medical Letter on Drugs and Therapeutics, 32(819), 53.
2. Adler, L., Resnick, S., Kunz, M., & Devinsky, O. (1995). Open-label trial of venlafaxine in adults with attention deficit disorder. Psychopharmacology Bulletin, 31(4), 785-8.
3. Barkley, R. A. (1977). A review of stimulant drug research with hyperactive children. Journal of Child Psychology and Psychiatry, 18(2), 137-165.
4. Barrickman, L., Noyes, R., Kuperman, S., Schumacher, E., & Verda, M. (1991). Treatment of ADHD with fluoxetine: A preliminary trial. Journal of the American Academy of Child and Adolescent Psychiatry, 30(5), 762-767.
5. Barrickman, L. L., Perry, P. J., Allen, A. J., Kuperman, S., Arndt, S. V., & Herrmann, K. J., et al. (1995). Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 34(5), 649-657.
6. Bench, C. J., Frith, C. D., Grasby, P. M., Friston, K. J., Paulesu, E., Frackowiak, R. S., et al. (1993). Investigations of the functional anatomy of attention using the Stroop test. Neuropsychologia, 31(9), 907-922.
7. Biederman, J., Baldessarini, R. J., Goldblatt, A., Lapey, K. A., Doyle, A., & Hesslein, P. S. (1993). A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic finding in children and adolescents treated with desipramine. Journal of the American Academy of Child and Adolescent Psychiatry, 32(4), 805-813.
8. Biederman, J., Baldessarini, R. J., Wright, V., Keenan, K., & Faraone, S. (1993). A double-blind placebo controlled study of desipramine in the treatment of ADD: III. Lack of impact of comorbidity and family history factors on clinical response. Journal of the American Academy of Child and Adolescent Psychiatry, 32(1), 199-204.
9. Biederman, J., Baldessarini, R. J., Wright, V., Knee, D., & Harmatz, J. S. (1989). A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy. Journal of the American Academy of Child and Adolescent Psychiatry, 28(5), 777-784.
10. Biederman, J., Gastfriend, D. R., & Jellinek, M. S. (1986). Desipramine in the treatment of children with attention deficit disorder. Journal of Clinical Psychopharmacology, 6(6), 359-363.
11. Biederman, J., Mick, E., Prince, J., Bostic, J. Q., Wilens, T. E., Spencer, T., et al. (1999). Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 9(4), 247-56.
12. Biederman, J., Thisted, R. A., Greenhill, L. L., & Ryan, N. D. (1995). Estimation of the association between desipramine and the risk for sudden death in 5- to 14-year-old children. Journal of Clinical Psychiatry, 56(3), 87-93.
13. Buitelaar, J. K., van der Gaag, R. J., Swaab-Barneveld, H., & Kuiper, M. (1996). Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder: Clinical efficacy and side-effects. Journal of Child Psychology and Psychiatry, 37(5), 587-595.
14. Casat, C. D., Pleasants, D. Z., Schroeder, D. H., & Parler, D. W. (1989). Bupropion in children with attention deficit disorder. Psychopharmacology Bulletin, 25(2), 198-201.
15. Casat, C. D., Pleasants, D. Z., & Van Wyck Fleet, J. (1987). A double-blind trial of bupropion in children with attention deficit disorder. Psychopharmacology Bulletin, 23(1), 120-122.
16. Castellanos, F. X., Giedd, J. N., Elia, J., Marsh, W. L., Ritchie, G. F., Hamburger, S. D., et al. (1997). Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: Effects of stimulant and dose. Journal of the American Academy of Child and Adolescent Psychiatry, 36(5), 589-596.
17. Chappell, P. B., Riddle, M. A., Scahill, L., Lynch, K. A., Schultz, R., Arnsten, A., et al. (1995). Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 34(9), 1140-1146.
18. Conners, C. K., Casat, C. D., Gualtieri, C. T., Weller, E., Reader, M., Reiss, A., et al. (1996). Bupropion hydrochloride in attention deficit disorder with hyperactivity. Journal of the American Academy of Child and Adolescent Psychiatry, 35(10), 1314-1321.
19. Connor, D. F., Ozbayrak, K. R., Benjamin, S., Ma, Y., & Fletcher, K. E. (1997). A pilot study of nadolol for overt aggression in developmentally delayed individuals. Journal of the American Academy of Child and Adolescent Psychiatry, 36(6), 826-834.
20. Cox, W. H. Jr. (1982). An indication for use of imipramine in attention deficit disorder. American Journal of Psychiatry, 139(8), 1059-1060.
21. Dillon, D. C., Salzman, I. J., & Schulsinger, D. A. (1985). The use of imipramine in Tourette's syndrome and attention deficit disorder: Case report. Journal of Clinical Psychiatry, 46(8), 348-349.
22. DuPaul, G. J., Barkley, R. A., & McMurray, M. B. (1994). Response of children with ADHD to methylphenidate: Interaction with internalizing symptoms. Journal of the American Academy of Child and Adolescent Psychiatry, 33(6), 894-903.
23. Findling, R. L., Schwartz, M. A., Flannery, D. J., & Manos, M. J. (1996). Venlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial. Journal of Clinical Psychiatry, 57(5), 184-189.
24. Frazier, J. A., Meyer, M. C., Biederman, J., Wozniak, J., Wilens, T. E., Spencer, T. J., et al. (1999). Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. Journal of the American Academy of Child and Adolescent Psychiatry, 38(8), 960-965.
25. Fung, Y. K. (1988). Postnatal behavioural effects of maternal nicotine exposure in rats. Journal of Pharmacy and Pharmacology 40(12), 870-872.
26. Fung, Y. K., & Lau, Y. S. (1989). Effects of prenatal nicotine exposure on rat striatal dopaminergic and nicotinic systems. Pharmacology Biochemistry and Behavior, 33(1), 1-6.
27. Gadow, K. D., Nolan, E. E., & Sverd, J. (1992). Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings. Journal of the American Academy of Child and Adolescent Psychiatry, 31(3), 462-471.
28. Gadow, K. D., Sverd, J., Sprafkin, J., Nolan, E. E., & Ezor, S. N. (1995). Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder. Archives of General Psychiatry, 52(6), 444-455.
29. Gadow, K. D., Sverd, J., Sprafkin, J., Nolan, E. E., & Grossman, S. (1999). Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Archives of General Psychiatry, 56(4), 330-336.
30. Garfinkel, B. D., Wender, P. H., Sloman, L., & O'Neill, I. (1983). Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children. Journal of the American Academy of Child and Adolescent Psychiatry, 22, 343-348.
31. Gastfriend, D. R., Biederman, J., & Jelfinek, M. S. (1985). Desipramine in the treatment of attention deficit disorder in adolescents. Psychopharmacology Bulletin, 21(1), 144-145.
32. Gittelman, R. (1980). Childhood disorders. In: D. Klein, F. Quitkin, A. Rifkin, & R. Gittelman (Eds.), Drug treatment of adult and child psychiatric disorders (pp. 576-756). Baltimore: Williams and Wilkins.
33. Gittelman-Klein, R. (1974). Pilot clinical trial of imipramine in hyperkinetic children. In: C. K. Conners (Ed.), Clinical use of stimulant drugs in children (pp. 192-201). The Hague, Netherlands: Excerpta Medica.
34. Greenberg, L., Yellin, A., Spring, C., & Metcalf, M. (1975). Clinical effects of imipramine and methylphenidate in hyperactive children. International Journal of Mental Health, 4, 144-156.
35. Gross, M. D. (1973). Imipramine in the treatment of minimal brain dysfunction in children. Psychosomatics, 14(5), 283-285.
36. Gualtieri, C. T., & Evans, R. W. (1988). Motor performance in hyperactive children treated with imipramine. Perceptual and Motor Skills, 66(3), 763-769.
37. Gunning, B. (1992). A controlled trial of clonidine in hyperkinetic children. Sophia Netherlands: Department of Child and Adolescent Psychiatry, Academic Hospital Rotterdam.
38. Hedges, D., Reimherr, F. W., Rogers, A., Strong, R., & Wender, P. H. (1995). An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder. Psychopharmacology Bulletin, 31(4), 779-783.
39. Heiligenstein, J. H., Spencer, T., Paries, D., Biederman, J., & Conners, C. K. (2000). Atomoxetine, a non-stimulant, noradrenergic enhancer for ADHD: double-blind treatment results. Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New York, NY.
40. Hoge, S. K., & Biederman, J. (1986). A case of Tourette's syndrome with symptoms of attention deficit disorder treated with desipramine. Journal of Clinical Psychiatry, 47(9), 478-479.
41. Hornig-Rohan, M., & Amsterdam, J. (1995). Venlafaxine vs. stimulant therapy in patients with dual diagnoses of ADHD and depression. In: New Clinical Drug Evaluation Unit Program. Orlando, FL.
42. Horrigan, J. P., & Barnhill, L. J. (1995). Guanfacine for treatment of attention-deficit hyperactivity disorder in boys. Journal of Child and Adolescent Psychophamacology, 5, 215-223.
43. Huessy, H., & Wright, A. (1970). The use of imipramine in children's behavior disorders. Acta Paedopsychiatrie, 37(7), 194-199.
44. Hunt, R. D. (1987). Treatment effects of oral and transdermal clonidine in relation to methylphenidate: an open pilot study in ADD-H. Psychopharmacology Bulletin, 23(1), 111-114.
45. Hunt, R. D., Arnsten, A. F., & Asbell, M. D. (1995). An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 34(1), 50-54.
46. Hunt, R. D., Minderaa, R. B., & Cohen, D. J. (1985). Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutic trial. Journal of the American Academy of Child Psychiatry 24(5), 617-629.
47. Johns, J. M., Louis, T. M., Becker, R. F., & Means, L. W. (1982). Behavioral effects of prenatal exposure to nicotine in guinea pigs. Neurobehavioral Toxicology and Teratology 4(3), 365-369.
48. Jones, G. M., Sahakian, B. J., Levy, R., Warburton, D. M., & Gray, J. A. (1992). Effects of acute subcutaneous nicotine on attention, information and short-term memory in Alzheimer's disease. Psychopharmacology 108(4), 485-494.
49. Konkol, R., Fischer, M., & Newby, R. (1990). Double-blind, placebo-controlled stimulant trial in children with Tourette's syndrome and ADHD: Abstract. Annals of Neurology 28, 424.
50. Kratochvil, C. J., Bohac, D., Harrington, M., Baker, N., May, D., & Burke, W. J. (2001). An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 11(2), 167-170.
51. Kupietz, S. S., & Balka, E. B. (1976). Alterations in the vigilance performance of children receiving amitriptyline and methylphenidate pharmacotherapy. Psychopharmacology 50(1), 29-33.
52. Landgraf, J. M., Rich, M., & Rappaport, L. (2002). Measuring quality of life in children with attention-deficit/hyperactivity disorder and their families: Development and evaluation of a new tool. Archives of Pediatrics & Adolescent Medicine, 156(4), 384-91.
53. Law, S. F., & Schachar, R. J. (1999). Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder? Journal of the American Academy of Child and Adolescent Psychiatry 38(8), 944-951.
54. Levin, E. D., Conners, C. J., Sparrow, E., Hinton, S. C., Erhardt, D., Meck, W. H., et al. (1996). Nicotine effects on adults with attention-deficit/ hyperactivity disorder. Psychopharmacology 123(1), 55-63.
55. Luh, J., Pliszka, S., Olvers, R., & Tatum, R. (1996). An open trial of venlafaxine in the treatment of attention deficit hyperactivity disorder: A pilot study. San Antonio: The University of Texas Health Science Center at San Antonio.
56. Mattes, J. A. (1986). Propranolol for adults with temper outbursts and residual attention deficit disorder. Journal of Clinical Psychopharmacology, 6(5), 299-302.
57. Meck, W. H., & Church, R. M. (1987). Cholinergic modulation of the content of temporal memory. Behavioral Neuroscience, 101(4), 457-464.
58. Mereu, G., Yoon, K. W., Gessa, G. L., Naes, L., & Westfall, T. (1987). Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. European Journal of Pharmacology, 141(3), 395-399.
59. Michelson, D. L., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F. R., et al. (2001). Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study. Pediatrics, 108(5), E83.
60. Milberger, S., Biederman, J., Faraone, S., Chen, L., & Jones, J. (1997). ADHD is associated with early initiation of cigarette smoking in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 36(1), 37-43.
61. Milberger, S., Biederman, J., Faraone, S. V., Chen, L., Jones, J. (1996). Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children? American Journal of Psychiatry, 153(9), 1138-1142.
62. National Institute of Mental Health (1996). Alternative Pharmacology of ADHD (NIMH report). Rockville, MD: National Institute of Mental Health.
63. Parrott, A. C. & Winder, G. (1989). Nicotine chewing gum (2 mg, 4 mg) and cigarette smoking: Comparative effects upon vigilance and heart rate. Psychopharmacology, 97(2), 257-261.
64. Peeke, S. C. & Peeke, H. V. (1984). Attention, memory, and cigarette smoking. Psychopharmacology, 84(2), 205-216.
65. Pliszka, S. R. (1989). Effect of anxiety on cognition, behavior, and stimulant response in ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 28(6), 882-887.
66. Pomerleau, O. F., Downey, K. K., Stelson, F. W., & Pomerleau, C. S. (1996). Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. Journal of Substance Abuse, 7(3), 373-378.
67. Prince, J. B., Wilens, T. E., Biederman, J., Spencer, T. J., Millstein, R., Polisner, D. A., et al. (2000). A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 10(3), 193-204.
68. Quinn, P. O., & Rapoport, J. L. (1975). One-year follow-up of hyperactive boys treated with imipramine or methylphenidate. American Journal of Psychiatry, 132(3), 241-245.
69. Rapoport, J. L., Quinn, P. O., Bradbard, G., Riddle, K. D., & Brooks, E. (1974). Imipramine and methylphenidate treatment of hyperactive boys: A double-blind comparison. Archives of General Psychiatry, 30(6), 789-793.
70. Rapport, M. D., Carlson, G. A., Kelly, K. L., & Pataki, C. (1993). Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function. Journal of the American Academy of Child and Adolescent Psychiatry, 32(2), 333-342.
71. Ratey, J., Greenberg, M., & Lindem, K. (1991). Combination of treatments for attention deficit disorders in adults. Journal of Nervous and Mental Disorders, 176(11), 699-701.
72. Riddle, M. A., Hardin, M. T., Cho, S. C., Woolston, J. L., & Leckman, J. F. (1988). Desipramine treatment of boys with attention-deficit hyperactivity disorder and tics: preliminary clinical experience. Journal of the American Academy of Child and Adolescent Psychiatry, 27(6), 811-814.
73. Scahill, L., Chappell, P. B., Kim, Y. S., Schultz, R. T., Katsovich, L., Shepherd, E., et al. (2001). A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. American Journal of Psychiatry, 158(7), 1067-74.
74. Silva, R. R., Munoz, D. M., & Alpert, M. (1996). Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder: A metaanalysis. Journal of the American Academy of Child & Adolescent Psychiatry, 35(3), 352-358.
75. Singer, S., Brown, J., Quaskey, S., Rosenberg, L., Mellits, E., & Denckla, M. (1994). The treatment of attention-deficit hyperactivity disorder in tourette's syndroms: A double-blind placebo-controlled study with clonidine and desipramine. Pediatrics, 95, 74-82.
76. Spencer, T., Biederman, J., Coffey, B., Geller, D., Crawford, M., Bearman, S. K., et al. (2002). A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 59(1), 649-56.
77. Spencer, T., Biederman, J., Coffey, B., Geller, D., Wilens, T., & Faraone, S. (1999). The 4-year course of tic disorders in boys with attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 842-847.
78. Spencer, T., Biederman, J., Heiligenstein, J., Wilens, T., Paries, D., Prince, J. et al. (2001). An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 11(3), 251-265.
79. Spencer, T., Biederman, J., Kerman, K., Steingard, R., & Wilens, T. (1993). Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's Syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 32(2), 354-360.
80. Spencer, T., Biederman, J., & Wilens, T. (1998a). Growth deficits in children with attention deficit hyperactivity disorder. Pediatrics, 102(2pt3), 501-6.
81. Spencer, T., Biederman, J., Wilens, T., Prince, J., Hatch, M., Jones, J., et al. (1998b). Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry, 155(5), 693-695.
82. Spencer, T., Biederman, J., Wilens, T., Steingard, R., & Geist, D. (1993). Nortriptyline in the treatment of children with attention deficit hyperactivity disorder and tic disorder or Tourette's syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 32(1), 205-210.
83. Spencer, T. J., Biederman, J., Wilens, T., Harding, M., O'Donnell, D., & Griffin, S. (1996). Pharmacotherapy of attention deficit hyperactivity disorder across the life cycle: A literature review. Journal of the American Academy of Child and Adolescent Psychiatry, 35(4), 409-432.
84. Steingard, R., Biederman, J., Spencer, T., Wilens, T., & Gonzalez, A. (1993). Comparison of clonidine response in the treatment of attention deficit hyperactivity disorder with and without comorbid tic disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 32(2), 350-353.
85. Swanson, J., Kinsbourne, M., Roberts, W., & Zucker, K. (1978). Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics, 61(11), 21-24.
86. Tannock, R., Ickowicz, A., & Schachar, R. (1995). Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. Journal of the American Academy of Child and Adolescent Psychiatry, 34(7), 886-896.
87. Taylor, E., Schachar, R., Thorley, G., Wieselberg, H. M., Everitt, B., & Rutter, M. (1987). Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour. Psychological Medicine, 17(1), 121-143.
88. Tourette's Syndrome Study Group (2002). Treatment of ADHD in children with tics: a randomized controlled trial. Neurology, 58(4), 527-536.
89. Trott, G. E., Friese, H. J., Menzel, M., & Nissen, G. (1991). Effectiveness and tolerance of the selective MAO-A inhibitor moclobemide in children with hyperkinetic syndrome Jugendpsychiat. 19(4), 248-253.
90. Voelker, S., Lachar, D., & Gdowski, C. L. (1983). The personality inventory for children and response to methylphenidate: Preliminary evidence for predictive validity. Journal of Pediatric Psychology, 8(2), 161-169.
91. Watter, N. & Dreyfuss, F. E. (1973). Modifications of hyperkinetic behavior by nortriptyline. Virginia Medical Monthly, 100(2), 123-126.
92. Wender, P. H. & Reimherr, F. W. (1990). Bupropion treatment of attention-deficit hyperactivity disorder in adults. American Journal of Psychiatry, 147(8), 1018-1020.
93. Werry, J. (1980). Imipramine and methylphenidate in hyperactive children. Journal of Child Psychology and Psychiatry, 21, 27-35.
94. Wesnes, K. & Warburton, D. M. (1984). The effects of cigarettes of varying yield on rapid information processing performance. Psychopharmacology, 82(4), 338-342.
95. Westfall, T., Grant, H., & Perry, H. (1983). Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors. General Pharmacology, 14(3), 321-325.
96. Wilens, T. E., Biederman, J., Abrantes, A. M., & Spencer, T. J. (1996). A naturalistic assessment of protriptyline for attention-deficit hyperactivity disorder. Journal of American Academy of Child and Adolescent Psychiatry, 35(11), 1485-1490.
97. Wilens, T. E., Biederman, J., Geist, D. E., & Steingard, R., Spencer, T. (1993). Nortriptyline in the treatment of attention deficit hyperactivity disorder: A chart review of 58 cases. Journal of the American Academy of Child and Adolescent Psychiatry, 32(2), 343-349.
98. Wilens, T. E., Biederman, J. B., Mick, E., & Spencer, T. (1995). A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder. Journal of Nervous and Mental Diseases, 183, 48-50.
99. Wilens, T. E., Biederman, J., Prince, J., Spencer, T. J., Faraone, S. V., Warburton, R., et al. (1996). Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. American Journal of Psychiatry, 153(90), 1147-1153.
100. Wilens, T. E., Biederman, J., Spencer, T. J., Bostic, J., Prince, J., Monuteaux, M. C., et al. (1999). A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. American Journal of Psychiatry, 156(12), 1931-7.
101. Wilens, T. E. & Spencer, T. J. (1999). Combining methylphenidate and clonidine: A clinically sound medication option. Journal of the American Academy of Child and Adolescent Psychiatry, 38(5), 614-622.
102. Wilens, T. E., Spencer, T. J., Biederman, J., Girard, K., Doyle, R., Prince, J., et al. (2001). A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. American Journal of Psychiatry, 158(2), 282-288.
103. Winsberg, B. G., Bialer, I., Kupietz, S., & Tobias, J. (1972). Effects of imipramine and dextroamphetamine on behavior of neuropsychiatrically impaired children. American Journal of Psychiatry, 128(11), 1425-1431.
104. Yepes, L. E., Balka, E. B., Winsberg, B. G., & Bialer, I. (1977). Amitriptyline and methylphenidate treatment of behaviorally disordered children. Journal of Child Psychology and Psychiatry, 18, 39-52.